173 related articles for article (PubMed ID: 32067604)
1. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
2. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies.
Wang Y; Liu X; Yan P; Bi Y; Liu Y; Zhang ZJ
Curr Pharm Des; 2019; 25(23):2595-2601. PubMed ID: 31333095
[TBL] [Abstract][Full Text] [Related]
3. Observational Studies on the Association Between Post-diagnostic Metformin Use and Survival in Ovarian Cancer: A Systematic Review and Meta-Analysis.
Gong TT; Wu QJ; Lin B; Ruan SK; Kushima M; Takimoto M
Front Oncol; 2019; 9():458. PubMed ID: 31192140
[No Abstract] [Full Text] [Related]
4. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
5. Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
Lee DJ; McMullen CP; Foreman A; Huang SH; Lu L; Xu W; de Almeida JR; Liu G; Bratman SV; Goldstein DP
J Otolaryngol Head Neck Surg; 2019 Jul; 48(1):34. PubMed ID: 31345259
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
7. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies.
Yang J; Yang H; Cao L; Yin Y; Shen Y; Zhu W
Medicine (Baltimore); 2022 Dec; 101(49):e31799. PubMed ID: 36626437
[TBL] [Abstract][Full Text] [Related]
9. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
10. Immortal time bias exaggerates the effect of metformin on the risk of gastric cancer: A meta-analysis.
Wang YB; Tan LM; Luo L; Yan S; Huang Q; Wang Y; Deng T; Shi Y; Deng Y; Jin YH
Pharmacol Res; 2021 Mar; 165():105425. PubMed ID: 33453371
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
12. Metformin exposure and survival in head and neck cancer: A large population-based cohort study.
Alcusky M; Keith SW; Karagiannis T; Rabinowitz C; Louis DZ; Maio V
J Clin Pharm Ther; 2019 Aug; 44(4):588-594. PubMed ID: 31293011
[TBL] [Abstract][Full Text] [Related]
13. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Jiao Y; Liu D; Sun Y; Chen Z; Liu S
Front Pharmacol; 2022; 13():850750. PubMed ID: 35645803
[No Abstract] [Full Text] [Related]
14. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
15. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
Tian S; Lei HB; Liu YL; Chen Y; Dong WG
Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
[TBL] [Abstract][Full Text] [Related]
16. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis.
Wu HD; Zhang JJ; Zhou BJ
Clin Transl Oncol; 2021 Feb; 23(2):275-282. PubMed ID: 32507907
[TBL] [Abstract][Full Text] [Related]
17. Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus.
Li Q; Xu H; Sui C; Zhang H
Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101781. PubMed ID: 34332136
[TBL] [Abstract][Full Text] [Related]
18. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
19. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
[TBL] [Abstract][Full Text] [Related]
20. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]